Inflation, Real-Estate Numbers Featured in Short Week U.S. Monday Featured Earnings Goldman Sachs Group, Inc. (NYS ...

A April filing shows that Representative Josh Gottheimer reported a sale in Abbott Laboratories ABT, valued between $32,032 and $480,000. The transaction date is listed as April 10, 2025, with the ...

To get a sense of who is truly in control of Abbott Laboratories (NYSE:ABT), it is important to understand the ownership structure of the business. With 79% stake, institutions possess the maximum ...

A leader in Abbott's Heart Failure division announced that the company named Dr. Finn Gustafsson as the unit's chief medical ...

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

“A study of past stagflation-like period shows that it is a headwind for equities, but dividend strategies tend to be more ...

The importance of dividend stocks cannot be denied, even in today’s market environment, which is dominated by AI stocks. The ...

The new tariffs announced by President Donald Trump Wednesday afternoon are weighing on some top names in the medtech ...

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against e.l.f. Beauty, Inc. (“Elf” or the “Company”) (NYSE: ELF) and certain officers.

Abbott Laboratories (NYSE:ABT) recently announced successful outcomes from its TRILUMINATE™ Pivotal trial for the TriClip™ system, showcasing significant improvements in patient outcomes for tricuspid ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

UBS's CIO Americas wealth management team has spotlighted its top thirty picks from the S&P sectors as Q1 2025 wraps up. The ...